Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K ... Scinece 370 (6515), eabd4585, 2020 | 2502* | 2020 |
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2169 | 2020 |
Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome KR Engelhardt, S McGhee, S Winkler, A Sassi, C Woellner, ... Journal of Allergy and Clinical Immunology 124 (6), 1289-1302. e4, 2009 | 579 | 2009 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 451 | 2021 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 341 | 2021 |
DOCK8 deficiency: clinical and immunological phenotype and treatment options-a review of 136 patients SE Aydin, SS Kilic, C Aytekin, A Kumar, O Porras, L Kainulainen, ... Journal of clinical immunology 35, 189-198, 2015 | 295 | 2015 |
Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized … AO Eifan, T Akkoc, A Yildiz, S Keles, C Ozdemir, NN Bahceciler, IB Barlan Clinical & Experimental Allergy 40 (6), 922-932, 2010 | 284 | 2010 |
Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like disorder caused by loss-of-function mutations in LRBA LM Charbonnier, E Janssen, J Chou, TK Ohsumi, S Keles, JT Hsu, ... Journal of Allergy and Clinical Immunology 135 (1), 217-227. e9, 2015 | 274 | 2015 |
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation HH Jabara, DR McDonald, E Janssen, MJ Massaad, N Ramesh, ... Nature immunology 13 (6), 612-620, 2012 | 241 | 2012 |
Human genetic and immunological determinants of critical COVID-19 pneumonia Q Zhang, P Bastard, A Cobat, JL Casanova Nature 603 (7902), 587-598, 2022 | 236 | 2022 |
The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency KR Engelhardt, ME Gertz, S Keles, AA Schäffer, EC Sigmund, C Glocker, ... Journal of Allergy and Clinical Immunology 136 (2), 402-412, 2015 | 195 | 2015 |
Inherited DOCK2 deficiency in patients with early-onset invasive infections K Dobbs, C Domínguez Conde, SY Zhang, S Parolini, M Audry, J Chou, ... New England Journal of Medicine 372 (25), 2409-2422, 2015 | 192 | 2015 |
Anaphylaxis to multiple pollen allergen sublingual immunotherapy. AO Eifan, S Keles, NN Bahceciler, IB Barlan | 189 | 2007 |
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity V Béziat, J Li, JX Lin, CS Ma, P Li, A Bousfiha, I Pellier, S Zoghi, S Baris, ... Science immunology 3 (24), eaat4956, 2018 | 173 | 2018 |
DOCK8 deficiency: insights into pathophysiology, clinical features and management CM Biggs, S Keles, TA Chatila Clinical Immunology 181, 75-82, 2017 | 164 | 2017 |
A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes S Keles, E Karakoc-Aydiner, A Ozen, AG Izgi, A Tevetoglu, T Akkoc, ... Journal of allergy and clinical immunology 128 (4), 808-815. e7, 2011 | 145 | 2011 |
SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? Sancho-Shimizu V, Brodin P, Cobat A, Biggs CM, Toubiana J, Lucas CL ... J Exp Med 218 (6), e20210446., 2021 | 141 | 2021 |
Abatacept as a long-term targeted therapy for LRBA deficiency A Kiykim, I Ogulur, E Dursun, LM Charbonnier, E Nain, S Cekic, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (8), 2790-2800 …, 2019 | 138 | 2019 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 132 | 2022 |
Defects along the TH17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome S Al Khatib, S Keles, M Garcia-Lloret, E Karakoc-Aydiner, I Reisli, H Artac, ... Journal of allergy and clinical immunology 124 (2), 342-348. e5, 2009 | 129 | 2009 |